Abstract
The papillomavirus E5 proteins are short, hydrophobic transforming proteins. The transmembrane E5 protein encoded by bovine papillomavirus transforms cells by activating the platelet-derived growth factor β receptor tyrosine kinase in a ligand-independent fashion. The bovine papillomavirus E5 protein forms a stable complex with the receptor, thereby inducing receptor dimerization and activation, trans-phosphorylation, and recruitment of cellular signaling proteins to the receptor. The E5 proteins of the human papillomaviruses also appear to affect the activity of growth factor receptors and their signaling pathways. The interaction of papillomavirus E5 proteins with a subunit of the vacuolar ATPase may also contribute to transformation. Further analysis of these unique mechanisms of viral transformation will yield new insight into the regulation of growth factor receptor activity and cellular signal transduction pathways.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Adam JL, Briggs MW, McCance DJ . 2000 Virology 272: 315–325
Adduci AJ, Schlegel R . 1999 J. Biol. Chem. 274: 10249–10258
Andresson T, Sparkowski J, Goldstein DJ, Schlegel R . 1995 J. Biol. Chem. 270: 6830–6837
Bohl J, Hull B, Vande Pol SB . 2001 J. Virol. 75: 513–521
Bouvard V, Matlashewski G, Gu Z-M, Storey A, Banks L . 1994 Virology 203: 73–80
Briggs MW, Adam JL, McCance D . 2001 Virology 280: 169–175
Burkhardt A, Willingham M, Gay C, Jeang K-T, Schlegel R . 1989 Virology 170: 334–339
Burnett S, Jareborg N, DiMaio D . 1992 Proc. Natl. Acad. Sci. USA 89: 5665–5669
Chen S-L, Tsai T-C, Han C-P, Tsao Y-P . 1996 J. Virol. 70: 3502–3508
Chen SL, Mounts P . 1990 J. Virol. 64: 3226–3233
Cohen BD, Goldstein DJ, Rutledge L, Vass WC, Lowy DR, Schlegel R, Schiller J . 1993a J. Virol. 67: 5303–5311
Cohen BD, Lowy DR, Schiller J . 1993b Mol. Cell. Biol. 13: 6462–6468
Conrad M, Bubb VJ, Schlegel R . 1993 J. Virol. 67: 6170–6178
Conrad M, Goldstein D, Andresson T, Schlegel R . 1994 Virology 200: 796–800
Crusius K, Auvinen E, Alonso A . 1997 Oncogene 15: 1437–1444
Crusius K, Kaszkin M, Kinzel V, Alonso A . 1999 Oncogene 18: 6714–6718
DiMaio D, Lai CC, Klein O . 1998 Annu. Rev. Microbiol. 52: 397–421
Drummond-Barbosa D, Vaillancourt RR, Kazlauskas A, DiMaio D . 1995 Mol. Cell. Biol. 15: 2570–2581
Faulkner Valle G, Banks L . 1995 J. Gen. Virol. 76: 1239–1245
Ghai J, Ostrow RS, Tolar J, McGlennen RC, Lemke TD, Tobolt D, Liu Z, Faras AJ . 1996 Proc. Natl. Acad. Sci. USA 93: 12879–12884
Goldstein DJ, Finbow ME, Andresson T, McLean P, Smith K, Bubb V, Schlegel R . 1991 Nature 352: 347–349
Goldstein D, Li W, Wang L-M, Heidaran MA, Aaronson SA, Shinn R, Schlegel R, Pierce JH . 1994 J. Virol. 68: 4432–4441
Goldstein D, Andresson T, Sparkowski JJ, Schlegel R . 1992a EMBO J. 11: 4851–4859
Goldstein D, Kulke R, DiMaio D, Schlegel R . 1992b J. Virol. 66: 405–413
Goldstein D, Toyama R, Dhar R, Schlegel R . 1992c Virology 190: 889–893
Gu Z, Matlashewski G . 1995 J. Virol. 69: 8051–8056
Horwitz BH, Weinstat D, Di Maio D . 1989 J. Virol. 63: 4515–4519
Horwitz BH, Burkhardt AL, Schlegel R, DiMaio D . 1988 Mol. Cell. Biol. 8: 4071–4078
Hwang E-S, Nottoli T, DiMaio D . 1995 Virology 211: 227–233
Klein O, Kegler-Ebo D, Su J, Smith S, DiMaio D . 1999 J. Virol. 73: 3264–3272
Klein O, Polack GW, Surti T, Kegler-Ebo D, Smith SO, DiMaio D . 1998 J. Virol. 72: 8921–8932
Kulke R, Horwitz BH, Zibello T, DiMaio D . 1992 J. Virol. 66: 505–511
Lai CC, Henningson C, DiMaio D . 2000 J. Biol. Chem. 275: 9832–9840
Lai CC, Henningson C, DiMaio D . 1998 Proc. Natl. Acad. Sci. USA 95: 15241–15246
Leechanachai P, Banks L, Moreau F, Matlashewski G . 1992 Oncogene 7: 19–25
Leptak C, Ramon y Cajal S, Kulke R, Riese DR, Horwitz BH, Dotto GP, DiMaio D . 1991 J. Virol. 65: 7078–7083 Correction: J. Virol. 66: 1833
Liu D-W, Tsao Y-P, Hsieh C-H, Hsieh J-T, Kung JT, Chiang C-L, Huang S-J, Chen S-L . 2000 J. Virol. 74: 9083–9089
Martin P, Vass W, Schiller JT, Lowy D, Velu TJ . 1989 Cell 59: 21–32
Maruo T, Tamasaki M, Ladines-Llave CA, Mochizuki M . 1992 Cancer 69: 1182–1187
Mattoon D, Gupta K, Doyon J, Loll PJ, DiMaio D . 2001 Oncogene 20: 3824–3834
Meyer AN, Xu Y-F, Webster MK, Smith AS, Dononghue DJ . 1994 Proc. Natl. Acad. Sci. USA 4634–4638
Nilson LA, Gottlieb R, Polack GW, DiMaio D . 1995 J. Virol. 69: 5869–5874
Nilson LA, DiMaio D . 1993 Mol. Cell. Biol. 13: 4137–4145
Oelze I, Kartenbeck J, Crusius K, Alonso A . 1995 J. Virol. 69: 4489–4494
Oetke C, Auvinen E, Pawlita M, Alonso A . 2000 Arch. Virol. 145: 2183–2191
Petti LM, Reddy V, Smith SO, DiMaio D . 1997 J. Virol. 71: 7318–7327
Petti L, DiMaio D . 1994 J. Virol. 68: 3582–3592
Petti L, DiMaio D . 1992 Proc. Natl. Acad. Sci. USA 89: 6736–6740
Petti L, Nilson L, DiMaio D . 1991 EMBO J. 10: 845–855
Petti LM, Ray A . 2000 Cell Growth Differ. 11: 395–408
Pim D, Collins M, Banks L . 1992 Oncogene 7: 27–32
Rho J, de Villiers E-M, Choe J . 1996 Virus Res. 44: 57–65
Riese II DJ, DiMaio D . 1995 Oncogene 10: 1431–1440
Rodriguez MI, Finbow ME, Alonso A . 2000 Oncogene 19: 3727–3732
Schapiro F, Sparkowski J, Adduci A, Suprynowicz F, Schlegel R, Grinstein S . 2000 Cell. Biol. 148: 305–316
Schlegel R, Wade-Glass M, Rabson MS, Yang Y-C . 1986 Science 233: 464–467
Settleman J, Fazeli A, Malicki J, Horwitz BH, DiMaio D . 1989 Mol. Cell. Biol. 9: 5563–5572
Sparkowski J, Mense M, Anders J, Schlegel R . 1996 J. Virol. 70: 2420–2430
Staebler A, Pierce JH, Brazinski S, Heidaran MA, Li W, Schlegel R, Goldstein DJ . 1995 J. Virol. 69: 6507–6517
Stoppler MC, Straight SW, Tsao G, Schlegel R, McCance DJ . 1996 Virology 223: 251–254
Straight SW, Herman B, McCance DJ . 1995 J. Virol. 69: 3185–3192
Straight SW, Hinkle PM, Jewers RJ, McCance DJ . 1993 J. Virol. 67: 4521–4532
Surti T, Klein O, Ascheim K, DiMaio D, Smith SO . 1998 Proteins: structure, function, and genetics 33: 601–612
Suprynowicz FA, Sparkowski J, Baege A, Schlegel R . 2000 J. Biol. Chem. 275: 5111–5119
Tervahauta A, Syrjanen S, Syrjanen K . 1994 Int. J. Gynecol. Pathol. 13: 230–240
Thomsen P, van Deurs B, Norrild B, Kayser L . 2000 Oncogene 19: 6023–6032
Thomsen P, Rudenko O, Berezin V, Norrild B . 1999 Biochim. Biophys. Acta. 1452: 285–295
Tomakidi P, Cheng H, Kohl A, Komposch G, Alonso A . 2000 Eur. J. Cell Biol. 79: 407–412
Tsao Y-P, Li L-Y, Tsai T-C, Chen S-L . 1996 J. Virol. 70: 7535–7539
Vali U, Kilk A, Ustav M . 2001 Intl. J. Biochem. Cell Biol. 33: 227–235
Venuti A, Salani D, Poggiali F, Manni V, Bagnato A . 1998 Virology 248: 1–5
Yoshimori T, Yamamoto A, Moriyama Y, Futai M, Tashiro Y . 1991 J. Biol. Chem. 266: 17707–17712
Acknowledgements
We thank Lisa Petti and Steven Smith and their colleagues for permission to cite unpublished work, Steven Smith and Omar Bakht for preparation of Figure 2, and Jan Zulkeski for typing this manuscript. The work in the authors' laboratory was supported by a grant from the National Institutes of Health (CA37157). D Mattoon is supported by a Bayer Predoctoral Fellowship.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
DiMaio, D., Mattoon, D. Mechanisms of cell transformation by papillomavirus E5 proteins. Oncogene 20, 7866–7873 (2001). https://doi.org/10.1038/sj.onc.1204915
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.onc.1204915
Keywords
This article is cited by
-
Designing of multi-epitope chimeric vaccine using immunoinformatic platform by targeting oncogenic strain HPV 16 and 18 against cervical cancer
Scientific Reports (2022)
-
Potential role of human papillomavirus proteins associated with the development of cancer
VirusDisease (2022)
-
Human papillomavirus-mediated carcinogenesis and tumor progression
Genome Instability & Disease (2021)
-
EGFR Protein Expression Relates with Tumor Histology, Methylation Status of EGFR and HPV16 E6 Viral Load in Oropharyngeal Carcinoma
Head and Neck Pathology (2021)
-
A novel bovine papillomavirus type in the genus Dyokappapapillomavirus
Archives of Virology (2017)